These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors? Maire F; Hammel P; Kianmanesh R; Hentic O; Couvelard A; Rebours V; Zappa M; Raymond E; Sauvanet A; Louvet C; Lévy P; Belghiti J; Ruszniewski P Surgery; 2009 Jan; 145(1):69-75. PubMed ID: 19081477 [TBL] [Abstract][Full Text] [Related]
7. Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: a safe approach for radical resection. Kianmanesh R; Sauvanet A; Hentic O; Couvelard A; Lévy P; Vilgrain V; Ruszniewski P; Belghiti J Ann Surg; 2008 Apr; 247(4):659-65. PubMed ID: 18362629 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial. Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348 [TBL] [Abstract][Full Text] [Related]
9. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423 [TBL] [Abstract][Full Text] [Related]
11. Endocrine tumors of the ileum: factors correlated with survival. Tomassetti P; Campana D; Piscitelli L; Casadei R; Nori F; Brocchi E; Santini D; Pezzilli R; Corinaldesi R Neuroendocrinology; 2006; 83(5-6):380-6. PubMed ID: 17016032 [TBL] [Abstract][Full Text] [Related]
12. Survival and prognostic factor analysis in patients with metastatic pancreatic endocrine carcinomas. Strosberg J; Gardner N; Kvols L Pancreas; 2009 Apr; 38(3):255-8. PubMed ID: 19066493 [TBL] [Abstract][Full Text] [Related]
13. Pancreatectomy for non-pancreatic malignancies results in improved survival after R0 resection. Varker KA; Muscarella P; Wall K; Ellison C; Bloomston M World J Surg Oncol; 2007 Dec; 5():145. PubMed ID: 18162131 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features and surgical outcome of isolated metastasis of renal cell carcinoma. Akatsu T; Shimazu M; Aiura K; Ito Y; Shinoda M; Kawachi S; Tanabe M; Ueda M; Kitajima M; Kitagawa Y Hepatogastroenterology; 2007 Sep; 54(78):1836-40. PubMed ID: 18019729 [TBL] [Abstract][Full Text] [Related]
15. The impact of obesity on outcomes following pancreatectomy for malignancy. Benns M; Woodall C; Scoggins C; McMasters K; Martin R Ann Surg Oncol; 2009 Sep; 16(9):2565-9. PubMed ID: 19557479 [TBL] [Abstract][Full Text] [Related]
16. Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas. Bahra M; Jacob D; Pascher A; Plockinger U; Kristiansen G; Neuhaus P; Langrehr JM J Gastroenterol Hepatol; 2007 Jun; 22(6):930-5. PubMed ID: 17489964 [TBL] [Abstract][Full Text] [Related]